Blood substitutes: Haemoglobin and fluorocarbon solutions;Les transporteurs de l'oxygene: Solutions d'hemoglobine et fluorocarbones

Sang Thrombose Vaisseaux

Volumn 8, Issue 8, 1996, Pages 511-517

  Sirieix, Didier ^a   Nicolas Robin, Armelle ^a   Baron, Jean François ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; FLUOROCARBON; FLUOSOL; HEMOGLOBIN; OXYFLUOR; PERFLUOROOCTYL BROMIDE; PLURONIQUE F68; UNCLASSIFIED DRUG;

BLEEDING; BLOOD TRANSFUSION; HEMODILUTION; HUMAN; OXYGEN TRANSPORT; REVIEW;

EID: 0029803505     PISSN: 09997385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Amberson WR, Jennings JJ, Rhode CM, Clinical experience with hemoglobin-saline solution. J Appl Physiol 1949; 1: 469-89.
2. Savitsky JP, Doczi J, Black J, Arnold JD. A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther 1978; 23: 73-80.
3. Azari M, Rohn K, Picken J. Diaspirin crosslinked hemoglobin (DCLHb): characterization of the process and the product manufactured under GMP requirements for clinical studies. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 701-8.
4. Farmer M, Ebeling A, Marshall T, et al. Validation of virus inactivation by heat treatment in the manufacture of diaspirin crosslinked hemoglobin. Biomater Artif Cells Immobil Biotechnol 1992; 20: 429-33.
5. Gould SA, Rosen AL, Sehgal LR, Sehqal HL, Moss GS. Polymerized pyridoxylated hemoglobin: efficacy as an O2 carrier. J Trauma 1986; 26: 903-8.
6. Chatterjee R, Welty EV, Walder RY, et al. Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1-lysine 99 alpha 2). J Biol Chem 1986; 261: 9929-37.
7. Shoemaker SA, Gerber MJ, Evans GL, Archer-Paik LE, Scoggin CH. Initial clinical experience with a rationally designed, genetically engineered recombinant human hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 457-65
8. Hughes GS Jr, Francome SF, Antal EJ, et al. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects. J Lab Clin Med 1995; 126: 444-51.
9. Ning J, Anderson PJ, Biro GP. Resuscitation of bled dogs with pyridoxalated-polymerized hemoglobin solution. Biomater Artif Cells Immobil Biotechnol 1992, 20. 525-30.
10. Rabinovici R, Rudolph AS, Ligler FS, Yue TL, Feuerstein G. Liposomeencapsulated hemoglobin: an oxygen-carrying fluid. Circ Shock 1990; 32: 1-17.
11. Vlahakes GJ, Lee R, Jacobs EE Jr, La Raia PJ, Austen WG. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement. J Thorac Cardiovasc Surg 1990; 100: 379-88.
12. Przybelski RJ, Malcolm DS, Burris DG, Winslow RM. Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med 1991; 117: 143-51.
13. Macdonald VW, Motterlini R. Vasoconstrictor effects in isolated rabbit heart perfused with bis(3,5-dibromosalicyl)fumarate cross-linked hemoglobin (alpha Hb). Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 565-75.
14. Malcolm D, Kissinger D, Garrioch M Diaspirin cross-linked hemoglobin solution as a resuscitative fluid following severe hemorrhage in the rat. Biomater Artif Cells Immobil Biotechnol 1992; 20: 495-7.
15. McKenzie JE, Cost EA, Scandling DM, Savage RW. Effects of diasprin cross-linked hemoglobin (DCLHb) on cardiac function and ECG in the swine. Biomater Artif Cells Immobil Biotechnol 1992 ; 20: 683-7.
16. Bilello K, Schultz S, Powell C, Jaffin J, Cole F, Malcolm D. Diaspirin crosslinked hemoglobin (DCLHb): control of pressor effect with antihypertensive agents. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 819-25.
17. Bush S, Marshall T, Spicuzza J, Nelson D. Diaspirin crosslinked hemoglobin (DCLHb): bioanalytical studies in swine. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 917-22
18. Sharma AC, Rebello S, Gulati A. Regional circulatory and systemic hemodynamic effects of diaspirin cross-linked hemoglobin in the rat. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 593-602.
19. Sharma AC, Singh G, Gulati A. Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 1995; 269: H1379-88.
20. Gulati A, Rebello S. Diaspirin cross-linked hemoglobin (DCLHb): involvement of adrenergic mechanisms in the pressor effect. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 603-12.
21. Gulati A, Sharma AC, Singh G. Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 1996; 24: 137-47.
22. Sharma AC, Gulati A. Yohimbine modulates diaspirin crosslinked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit Care Med 1995; 23: 874-84.
23. Hughes GS Jr, Yancey EP, Albrecht R, et al. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans. Clin Pharmacol Ther 1995; 58: 434-43.
24. Swan SK, Halstenson CE, Collins AJ, Colburn WA, Blue J, Przybelski RJ. Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients. Am J Kidney Dis 1995; 26: 918-23.
25. Riess JG. Present trends in fluorocarbon-based blood substitutes. Life Support Syst 1984; 2: 273-6.
26. Riess JG. Fluorocarbon-based oxygen carriers : new orientations. Artif Organs 1991; 15: 408-13.
27. Riess JG, Cornelus C, Follana R, et al. Novel fluorocarbon-based injectable oxygen-carrying formulations with long-term room-temperature storage stability. Adv Exp Med Biol 1994; 345: 227-34.
28. Cowley MJ, Snow FR, Di Sciascio G, Kelly K, Guard C, Nixon JV. Perfluorochemical perfusion during coronary angioplasty in unstable and high-risk patients. Circulation 1990; 81: IV 27-34.
29. Riess JG, Dalfors JL, Hanna GK, et al. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy. Biomater Artif Cells Immobil Biotechnol 1992; 20: 839-42.
30. Flaim SF. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 1043-54.
31. Faithfull NS. Oxygen delivery from fluorocarbon emulsions-aspects of convective and diffusive transport. Biomater Artif Cells Immobil Biotechnol 1992; 20: 797-804.
32. Spiess BD, Braverman B, Woronowicz AW, Ivankovich AD. Protection from cerebral air emboli with perfluorocarbons in rabbits. Stroke 1986; 17: 1146-9.
33. Hirschl RB, Pranikoff T, Wise C, et al Initial experience with partial liquid ventilation in adult patients with the ccute respiratory distress syndrome. Jama 1996; 275: 383-9.